India-based Venus Remedies has secured marketing approval in Argentina for its antibiotic drug used to treat serious bacterial infections, marking another step in the company’s global expansion strategy. The approval allows the pharmaceutical...
Aurobindo Pharma has received the Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (USFDA) for its Telangana-based oral solid dosage manufacturing unit, marking the successful closure of a key regulatory inspect...
Diabetes treatment access is set to improve in Canada after Orbicular Pharmaceutical Technologies announced it has received a Notice of Compliance (NOC) from Health Canada for its semaglutide injection, developed in partnership with Apotex Inc....
India has launched a nationwide childhood diabetes screening plan, aiming to improve early detection, ensure timely diabetes treatment, and provide long-term child healthcare across the country. The Centre’s new framework focuses on strengtheni...
Aurobindo Pharma’s biosimilars arm CuraTeQ Biologics has secured a major regulatory milestone, as it wins Canada nod for its cancer biosimilar, marking a significant step in the company’s global expansion in oncology treatmen...
India’s pharmaceutical sector is under renewed focus after Lilly supported Haryana’s crackdown on fake Mounjaro drug networks, following the seizure of counterfeit products in Gurugram. The action by the Haryana State Food and Drug Administra...
Pfizer Inc. has reported strong topline results from its phase 3 MagnetisMM-5 study, signaling a potential shift in myeloma treatment for patients with relapsed or refractory disease. The trial showed that Elrexfio significantly improved...
Abbott announced it has secured U.S. Food and Drug Administration clearance and CE Mark approval for its latest OCT imaging system, Ultreon 3.0, signaling a major move in complex coronary care. The platform combines high-resolution imaging with...
Solara Active Pharma Sciences has successfully cleared a US FDA inspection at its Puducherry manufacturing plant, earning a Voluntary Action Indicated (VAI) status and reinforcing its compliance with global pharmaceutical quality standar...
Global pharma giant AstraZeneca has achieved a major milestone with the Breztri Aerosphere asthma FDA approval, expanding treatment options for asthma patients worldwide. The U.S. Food and Drug Administration (FDA) has approved the..
, CDSCO.jpg)